Trial Profile
A Phase 2, 28 Day Parallel-Group, Double-Masked, Dose-Finding Study Comparing the Safety and Efficacy of PF-03187207 to Latanoprost
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Sep 2020
Price :
$35
*
At a glance
- Drugs Latanoprostene bunod (Primary) ; Latanoprost
- Indications Glaucoma; Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Bausch & Lomb
- 25 Jun 2014 New trial record